Table Of Contents

1. Introduction 21
1.1. Overview Of North America Drug Delivery Devices Market 21
1.2. Currency And Pricing 22
1.3. Limitation 22
1.4. Markets Covered 22
2. Market Segmentation 24
2.1. Markets Covered 24
2.2. Geographic Scope 25
2.3. Years Considered For The Study 26
2.4. Currency And Pricing 26
2.5. Research Methodology 27
2.6. Primary Interviews With Key Opinion Leaders 31
2.7. Secondary Sources 32
2.8. Assumptions 32
3. Market Overview 33
3.1. Drivers 34
3.1.1. Rising Prevalence Of Chronic Disease Such As Diabetes 34
3.1.2. Growth In The Development Of Biologics 35
3.1.3. Technological Development 36
3.2. Restraints 37
3.2.1. Risk Of Needle-Stick Injuries And Side Effects 37
3.3. Opportunities 38
3.3.1. Rising Acceptance Of Self Administering Drugs 38
3.3.2. Rising Demand For Biosimilars And Generic Drugs 39
3.3.3. Trend Of Merger And Acquisitions, And Collaborations 40
3.3.4. Focus On Patient Needs 41
3.3.5. Developing And New Emerging Revenue Pockets 42
3.4. Threats 43
3.4.1. Product Recalls 43
3.4.2. Stringent Regulatory And High Pricing 44
3.4.3. Patent Expiry And Patent Cliff 45
4. Executive Summary 46
5. Premium Insights 49
6. North America Drug Delivery Devices Market, By Product Type 52
6.1. Overview 53
6.2. North America Oral Drug Delivery Market, By Product Type 55
6.3. North America Solid Oral Drug Delivery Market,
By Product Type 58
6.4. North America Liquid Oral Drug Delivery Market,
By Product Type 60
6.5. North America Semi-Solid Oral Drug Delivery Market,
By Product Type 62
6.6. North America Pulmonary Drug Delivery Market,
By Product Type 64
6.7. North America Nebulizers Market, By Product Type 67
6.8. North America Injectable Drug Delivery Market,
By Product Type 69
6.9. North America Injectable Drug Delivery Devices,
By Product Type 71
6.9.1. North America Conventional Injectable Drug Delivery Devices Market 72
6.9.2. North America Self-Injection Drug Delivery Devices Market, By Product Type 76
6.10. North America Injectable Drug Delivery Formulations Market, By Product Type 80
6.11. North America Ophthalmic Drug Delivery Market,
By Product Type 83
6.12. North America Ophthalmic Drug Delivery Formulations Market,By Form 85
6.13. Ophthalmic Drug Delivery Devices, By Product Type 88
6.14. North America Nasal Drug Delivery Market, By Product Type 90
6.15. North America Topical Drug Delivery Market, By Product Type 92
6.16. North America Transdermal Drug Delivery Devices Market, By Product Type 94
6.17. North America Topical Drug Delivery Formulations Market, By Product Type 96
6.17.1. North America Semi Solid Topical Drug Delivery Formulations Market, By Type 97
6.17.2. North America Liquid Topical Drug Delivery Formulations Market, By Type 99
6.17.3. North America Solid Topical Drug Delivery Formulations Market, By Type 100
6.18. North America Implantable Drug Delivery Market,
By Product Type 102
6.19. North America Transmucosal Drug Delivery Market,
By Product Type 104
6.20. North America Oral Transmucosal Drug Delivery Market, By Product Type 106
6.21. North America Oral Transmucosal Drug Delivery Market, By Product Type 108
7. North America Drug Delivery Devices Market, By End User 110
7.1. Overview 111
8. North America Drug Delivery Devices Market, By Distribution Channel 114
8.1. Overview 115
?
9. Drug Delivery Market, By Geography 117
9.1. North America Drug Delivery Devices Market 118
9.2. U.S. Drug Delivery Devices Market 140
9.3. Canada Drug Delivery Devices Market 159
9.4. Mexico Drug Delivery Devices Market 178
10. North America Drug Delivery Devices Market, Company Share 197
10.1. Company Share Analysis; North America 197
11. Company Profiles 199
11.1. Bayer Ag 199
11.1.1. Company Overview 199
11.1.2. Revenue Analysis 200
11.1.3. Product Portfolio 200
11.1.4. Recent Developments 201
11.2. F. Hoffmann-La Roche Ltd 204
11.2.1. Company Overview 204
11.2.2. Revenue Analysis 204
11.2.3. Product Portfolio 205
11.2.4. Recent Developments 210
11.3. Glaxosmithkline Plc 212
11.3.1. Company Overview 212
11.3.2. Revenue Analysis 212
11.3.3. Product Portfolio 213
11.3.4. Recent Developments 213
11.4. Johnson & Johnson Services, Inc. 215
11.4.1. Company Overview 215
11.4.2. Revenue Analysis 216
11.4.3. Product Portfolio 217
11.4.4. Recent Developments 218
11.5. Novartis 221
11.5.1. Company Overview 221
11.5.2. Revenue Analysis 221
11.5.3. Product Portofolio 222
11.5.4. Recent Developments 222
11.6. Pfizer, Inc. 227
11.6.1. Company Overview 227
11.6.2. Revenue Analysis 227
11.6.3. Product Portfolio 228
11.6.4. Recent Developments 234
11.7. 3M 238
11.7.1. Company Overview 238
11.7.2. Revenue Analysis 238
11.7.3. Product Portfolio 239
11.7.4. Recent Developments 239
11.8. Antares Pharma, Inc. 240
11.8.1. Company Overview 240
11.8.2. Revenue Analysis 240
11.8.3. Product Portfolio 241
11.8.4. Recent Developments 241
11.9. Merck & Co. 243
11.9.1. Company Overview 243
11.9.2. Revenue Analysis 244
11.9.3. Product Portfolio 244
11.9.4. Recent Developments 246
?
11.10. Sanofi 249
11.10.1. Company Overview 249
11.10.2. Revenue Analysis 250
11.10.3. Product Portofolio 250
11.10.4. Recent Developments 251
12. Related Reports 254